Pharmacyte Biotech Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.80

-0.15 (-15.38%)

As of May 16, 2:32 AM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +3,347.3% upside

Low Target $20.43

Average Target $27.73

High Target $35.07

Current Price $0.80

Current
$0.80

Target
$27.73

$20.43 $27.73 avg $35.07

Scenario Analysis

Bear Case

$20.43

2,439.8%

Low target

Base Case

$27.73

+3,347.3%

Avg target

Bull Case

$35.07

+4,259.8%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$1.51

-46.7% from high

52-Week Low

$0.63

+27.7% from low

Target vs 52W High

$27.73

+1,736.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%